Machine-learning-based early prediction of end-stage renal disease in patients with diabetic kidney disease using clinical trials data.
Sunil B NagarajMichelle J PenaWenjun JuHiddo J Lambers Heerspinknull nullPublished in: Diabetes, obesity & metabolism (2020)
Despite large inter-patient variability, non-linear machine-learning models can be used to predict long-term ESRD in patients with type 2 diabetes and nephropathy using baseline demographic and clinical characteristics. The proposed method has the potential to create accurate and multiple outcome prediction automated models to identify high-risk patients who could benefit from therapy in clinical practice.
Keyphrases
- machine learning
- end stage renal disease
- chronic kidney disease
- peritoneal dialysis
- big data
- clinical trial
- clinical practice
- artificial intelligence
- deep learning
- type diabetes
- electronic health record
- case report
- stem cells
- randomized controlled trial
- phase ii
- wound healing
- bone marrow
- risk assessment
- study protocol
- single cell
- mesenchymal stem cells
- open label
- phase iii